Worldwide COVID-19 Diagnostics Industry to 2025 - Players Include Abbott Diagnostics, Applied BioCode and BillionToOne Among Others
Worldwide COVID-19 Diagnostics Industry to 2025 - Players Include Abbott Diagnostics, Applied BioCode and BillionToOne Among Others
DUBLIN, Sept. 21, 2021 /PRNewswire/ -- The "Global COVID-19 Diagnostics Market Forecast by Technology, Product, Channel and Country: Assay Volumes and Market Size Outlook to 2025 - Updated to Include 2020 Actuals" report has been added to ResearchAndMarkets.com's offering.
都柏林9月2021年21日/美通社/--“按技術、產品、渠道和國家劃分的全球新冠肺炎診斷市場預測：到2025年的化驗量和市場規模展望-更新為包括2020年實際數據”報告已添加到Research andMarkets.com的獻祭。
A new dynamic market is emerging for COVID-19-based diagnostics. Testing is moving into physicians' offices and even into the home.
基於新冠肺炎的診斷正在出現一個新的充滿活力的市場。檢測正在進入醫生的辦公室，甚至進入家庭。
Saliva tests? Handheld multiplex testers? Home based testing sticks? And what about the workplace market where safety is paramount? And what happens to the large laboratory capacity that was built up to handle a pandemic now in decline? Learn all about these changing markets in our latest report.
唾液測試？手持多路測試儀？家用測試棒？那麼，安全至上的工作場所市場又如何呢？而為應對目前正在衰退的大流行而建立起來的大型實驗室能力又發生了什麼？在我們最新的報告中瞭解所有這些不斷變化的市場。
Revenue, testing volumes, technology, products and channels - they are all looked at in this complete report that provides detailed breakdowns by country and regions. Get on top of the situation quickly with market guides and situation analysis.
收入、測試量、技術、產品和渠道-所有這些都在這份完整的報告中進行了分析，該報告提供了按國家和地區細分的詳細數據。通過市場指南和形勢分析快速掌握形勢。
Key Topics Covered:
涵蓋的主要主題：
1 Market Guides
1.1 COVID-19. Strategic Situation Analysis
1.2 COVID-19. Guidance for Executives
1.3 COVID-19. Guidance for Management Consultants and Investment Advisors
1市場指南1.1.新冠肺炎。戰略態勢分析1.2.新冠肺炎。對高管的指導1.3.新冠肺炎。管理顧問和投資顧問指南
2 Introduction and Market Definition
2.1 What are Pandemics?
2.2 The Role of Zoonosis
2.3 Market Definition
2.3.1 Assay Volumes
2.3.2 PCR
2.3.3 PCR Multiplex
2.3.4 SEQ
2.3.5 Antigen
2.3.6 Antibodies
2.3.7 Instruments
2.3.8 Reagents and Kits
2.3.9 Extract
2.3.10 Collect
2.3.11 Public
2.3.12 Hospital
2.3.13 Clinic
2.3.14 Workplace
2.3.15 DTC/OTC
2.3.16 Wastewater
2.4 Methodology
2.4.1 Authors
2.4.2 Sources
2.5 Historical Perspective on Pandemics
2.5.1 HIV/AIDS Pandemic 2005-2012
2.5.2 Flu Pandemic 1968
2.5.3 Asian Flu 1956-1958
2.5.4 Spanish Flu 1918
2.5.5 Sixth Cholera Pandemic 1910-1911
2.5.6 Flu Pandemic 1889-1890
2.5.7 The Black Death 1346-1353
2介紹和市場定義2.1什麼是流行病？2.2人畜共患病的作用2.3市場定義2.3.1化驗體積2.3.2 PCR2.3.3多聚酶鏈反應(PCR Multiplex)2.3.4序列2.3.5抗原2.3.6抗體2.3.7儀器2.3.8試劑和試劑盒2.3.9摘錄2.3.10代收2.3.11公眾2.3.12醫院2.3.13診所2.3.14工作場所2.3.15DTC/OTC2.3.16廢水2.4方法論2.4.1作者2.4.2來源2.5流行病的歷史透視2.5.1 2005-2012年艾滋病毒/艾滋病大流行2.5.2 1968年流感大流行2.5.3亞洲流感1956-19582.5.4 1918年西班牙流感2.5.5第六次霍亂大流行1910-1911年2.5.6流感大流行1889-1890年2.5.7黑死病1346-1353
3 The Pandemic Overview
3.1 What is a Virus?
3.1.1 Is a Virus Alive?
3.1.2 Viral Structure
3.1.3 The Viral Genome
3.1.4 Viral Mutation
3.2 The Coronavirus
3.2.1 Severe acute respiratory syndrome (SARS)
3.2.2 Middle East respiratory syndrome (MERS)
3.2.3 COVID-19. The SARS CoV 2 Virus
3.2.3.1 Signs and symptoms
3.2.3.2 Transmission
3.2.3.3 Diagnosis
3.2.3.4 Prevention
3.2.3.5 Management
3.2.3.6 Prognosis
3.2.3.7 A Note on Global Statistics Reporting
3.3 Pandemic Diagnostics
3.3.1 Risk Management - Spark and Spread
3.3.2 Dx Technology - Nucleic Acid Based
3.3.3 Dx Technology - Immunoassay
3.3.4 Time to Market and Preparedness Issues
3大流行概述3.1什麼是病毒？3.1.1病毒是活的嗎？3.1.2病毒結構3.1.3病毒基因組3.1.4病毒突變3.2冠狀病毒3.2.1嚴重急性呼吸系統綜合症(SARS)3.2.2中東呼吸綜合徵(MERS)3.2.3新冠肺炎。非典冠狀病毒2型病毒3.2.3.1體徵和症狀3.2.3.2變速箱3.2.3.3診斷3.2.3.4預防3.2.3.5管理3.2.3.6預後3.2.3.7關於全球統計報告的説明3.3大流行診斷3.3.1風險管理-火花和擴散3.3.2 Dx技術-以核酸為基礎3.3.3 Dx技術-免疫分析3.3.4上市時間和準備問題
4 Diagnostic Company Profiles
4.1 Abacus Diagnostica
4.2 Abbott Diagnostics
4.3 Accelerate Diagnostics
4.4 Acces Bio
4.5 Advanced Biological Laboratories
4.6 Agena Bioscience, Inc
4.7 Agilent/Dako
4.8 Altona Diagnostics
4.9 Alveo Technologies
4.10 Anatolia Geneworks
4.11 Applied BioCode
4.12 Applied DNA Sciences
4.13 Assurance Scientific Laboratories
4.14 Aus Diagnostics
4.15 Autobio Diagnostics
4.16 Beckman Coulter Diagnostics
4.17 Becton, Dickinson and Company
4.18 BGI Genomics Co. Ltd
4.19 BillionToOne
4.20 Binx Health
4.21 Biocartis
4.22 Biodesix Inc
4.23 BioFire Diagnostics (bioMerieux)
4.24 Biolidics Ltd
4.25 bioMerieux Diagnostics
4.26 Bioneer Corporation
4.27 Bio-Rad Laboratories, Inc
4.28 Bio-Reference Laboratories
4.29 Bosch Healthcare Solutions GmbH
4.30 Cepheid (Danaher)
4.31 Chembio
4.32 Co Diagnostics
4.33 Color Genomics
4.34 Cue Health
4.35 Curetis N.V. / Curetis GmbH
4.36 Diagenode Diagnostics
4.37 Diasorin S.p.A
4.38 Ellume
4.39 Enzo Life Sciences, Inc
4.40 Everywell
4.41 Fluxergy
4.42 Fulgent Genetics
4.43 Fusion Genomics
4.44 Genedrive
4.45 Genetic Signatures
4.46 GenMark Dx (Roche)
4.47 Gold Standard Diagnostics
4.48 Hologic
4.49 Illumina
4.50 Immunexpress
4.51 Inflammatix
4.52 Janssen Diagnostics
4.53 Karius
4.54 Laboratory Corporation of America
4.55 Letsgetchecked
4.56 Lexagene
4.57 Luminex Corp
4.58 LumiraDx
4.59 Mammoth Biosciences
4.60 Mayo Clinic Laboratories
4.61 Mbio Diagnostics
4.62 Meridian Bioscience
4.63 Mesa Biotech (Thermo Fisher)
4.64 Mobidiag (Hologic)
4.65 Nanomix
4.66 Novacyt
4.67 Orasure
4.68 Ortho Clinical Diagnostics
4.69 Oxford Nanopore Technologies
4.70 Perkin Elmer
4.71 Primerdesign (Novacyt)
4.72 Prominex
4.73 Qiagen Gmbh
4.74 quantumdx.com
4.75 Quest Diagnostics
4.76 Quidel
4.77 Randox Toxicology
4.78 Roche Molecular Diagnostics
4.79 SD Biosensor
4.80 Seegene
4.81 Sherlock Biosciences
4.82 Siemens Healthineers
4.83 Sona Nanotech
4.84 SpeeDx
4.85 Thermo Fisher Scientific Inc
4.86 Veredus Laboratories
4.87 Vircell
4.88 Visby Medical
4.89 YD Diagnostics
4.90 Zhejiang Orient Gene Biotech
4個診斷公司簡介4.1珠心算診斷4.2雅培診斷公司4.3加速診斷4.4 Acces Bio4.5高級生物實驗室4.6 Agena Bioscience，Inc.4.7安捷倫/達科4.8 Altona診斷4.9 Alveo Technologies4.10安納托利亞基因工程4.11應用生物編碼4.12應用DNA科學4.13保證科學實驗室4.14澳大利亞診斷公司4.15自動生物診斷4.16 Beckman Coulter Diagnostics4.17Becton，Dickinson and Company4.18華大基因有限公司4.19億對14.20 Binx運行狀況4.21 Biocartis4.22 BiodeSix公司4.23 BioFire診斷(BioMerieux)4.24 Biolidics Ltd4.25 BioMerieux診斷公司4.26 Bioneer公司4.27 Bio-Rad實驗室，Inc.4.28生物參考實驗室4.29博世醫療解決方案有限公司4.30造父變種(丹納赫)4.31化學生物4.32 CO診斷4.33顏色基因組學4.34提示健康4.35 Curetis N.V./Curetis GmbH4.36診斷節點診斷4.37 Diasorin S.p.A4.38 Ellume4.39恩佐生命科學公司4.40Everywell4.41浮能4.42富蘭特遺傳學4.43融合基因組學4.44 Genedrive4.45遺傳簽名4.46 Genmark Dx(羅氏)4.47金牌標準診斷4.48荷蘭學4.49照度4.50免疫快遞4.51火藥4.52 Janssen Diagnostics4.53卡利烏斯4.54美國實驗室公司4.55讓LetsgetChecked4.56Lexagene4.57 Luminex Corp4.58 LumiraDx4.59猛獁象生物科學4.60梅奧診所實驗室4.61 mBio診斷4.62經絡生物科學4.63梅薩生物科技(熱費舍爾(Thermo Fisher))4.64 Mobidiag(霍洛奇)4.65 Nanomix4.66 Novacyt4.67 Orasure4.68骨科臨牀診斷學4.69牛津納米孔技術4.70珀金·埃爾默4.71初級設計(Novacyt)4.72 Prominex4.73啟根股份有限公司4.74 quantumdx.com4.75 Quest Diagnostics4.76 Quidel4.77蘭度毒理學4.78羅氏分子診斷學4.79SD生物傳感器4.80 Seegene4.81夏洛克生物科學4.82西門子醫療保健公司4.83索納納米科技4.84 SpeeDx賽默飛世爾4.86 Veredus實驗室4.87 Vircell4.88 Visby Medical4.89 YD診斷程序4.90浙江東方基因生物技術
5 COVID-19 Diagnostics Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
5.2 LetsGetChecked Closes $150M Funding Round
5.3 Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay
5.4 Abbott Sees Sharp Decline in COVID-19 Test Revenue
5.5 Phosphorus Diagnostics Gets EUA for DTC C19 Test, Sample Collection Kit
5.6 NY Times Explores Multiplex Testing
5.7 Hologic Banking on MDx Acquisitions
5.8 Demand for Cepheid SARS-CoV-2 Point-of-Care Tests to Continue Through 2022
5.9 DiaSorin Acquires Luminex to Broaden MDx Portfolio, Expand US Presence
5.10 LumiraDx to Go Public Through SPAC
5.11 Eurofins Test Helps to ID Mutations
5.12 Roche Sees Growing Opportunities for Diagnostics
5.13 Roche to Acquire GenMark Diagnostics for $1.8B
5.14 Fulgent Genetics is to Use COVID-19 Testing Gains to Grow Clinical Sequencing
5.15 LexaGene Syndromic Panel Platform Lets Labs Customize Targets
5.16 FDA Grants EUAs for DTC Sample Collection Kit, Two Molecular Tests
5.17 At-Home Infectious Disease Test Developer Lucira Health Goes Public
5新冠肺炎診斷的最新進展5.1最新發展--重要性和如何使用本節5.1.1這些發展的重要性5.1.2如何使用本節5.2 LetsGetChecked完成1.5億美元融資5.3 Novacyt公司獲得多基因SARS-CoV-2檢測CE標誌，推出Ruo變異檢測5.4Abbott預計新冠肺炎測試收入大幅下降5.5磷診斷公司獲得用於DTC C19測試的EUA，樣本採集套件5.6《紐約時報》探索多路測試5.7收購MDX的荷蘭德銀行業務5.8對造父變種SARS-CoV-2點檢測的需求將持續到2022年5.9 DiaSorin收購Luminex擴大MDX產品組合，擴大美國業務5.10 LumiraDx將通過SPAC上市5.11 Eurofins檢測有助於識別突變5.12羅氏看到越來越多的診斷機會5.13羅氏將收購Genmark Diagnostics$1.8B5.14Fulgent Genetics公司將利用新冠肺炎測試成果擴大臨牀測序5.15 LexaGene綜合症狀小組平台讓實驗室定製目標5.16 FDA批准用於DTC樣本採集試劑盒和兩項分子測試的EUA5.17居家傳染病檢測開發商Lucira Health上市
6 The Global Market for COVID-19 Diagnostics
6.1 Global Market Overview by Country
6.1.1 Table - Global Market by Country
6.1.2 Chart - Global Market by Country
6.1.3 Table - Global Market by Country - Assay Volumes
6.2 Global Market by Technology - Overview
6.2.1 Table - Global Market by Technology
6.2.2 Chart - Global Market by Technology - Base/Final Year Comparison
6.2.3 Chart - Global Market by Technology - Base Year
6.2.4 Chart - Global Market by Technology - End Year
6.2.5 Chart - Global Market by Technology - Share by Year
6.2.6 Chart - Global Market by Technology - Segments Growth
6.3 Global Market by Product - Overview
6.3.1 Table - Global Market by Product
6.3.2 Chart - Global Market by Product - Base/Final Year Comparison
6.3.3 Chart - Global Market by Product - Base Year
6.3.4 Chart - Global Market by Product - End Year
6.3.5 Chart - Global Market by Product - Share by Year
6.3.6 Chart - Global Market by Product - Segments Growth
6.4 Global Market by Channel - Overview
6.4.1 Table - Global Market by Channel
6.4.2 Chart - Global Market by Channel - Base/Final Year Comparison
6.4.3 Chart - Global Market by Channel - Base Year
6.4.4 Chart - Global Market by Channel - End Year
6.4.5 Chart - Global Market by Channel - Share by Year
6.4.6 Chart - Global Market by Channel - Segments Growth
6新冠肺炎診斷的全球市場6.1按國家/地區劃分的全球市場概覽6.1.1表-按國家/地區劃分的全球市場6.1.2圖表-按國家/地區劃分的全球市場6.1.3表-按國家劃分的全球市場-化驗量6.2按技術劃分的全球市場-概述6.2.1表-按技術劃分的全球市場6.2.2圖表-按技術劃分的全球市場-基數/最後一年比較6.2.3圖表-按技術劃分的全球市場-基準年6.2.4圖表-按技術劃分的全球市場-年終6.2.5圖表-按技術劃分的全球市場-按年劃分的份額6.2.6圖表-按技術劃分的全球市場-細分市場增長6.3按產品劃分的全球市場-概述6.3.1表-按產品劃分的全球市場6.3.2圖表-按產品劃分的全球市場-基數/最後一年比較6.3.3圖表-按產品劃分的全球市場-基準年6.3.4圖表-按產品劃分的全球市場-年終6.3.5圖表-按產品劃分的全球市場-按年劃分的份額6.3.6圖表-按產品細分的全球市場-增長6.4按渠道劃分的全球市場-概述6.4.1表-按渠道劃分的全球市場6.4.2圖表-按渠道劃分的全球市場-基數/最後一年比較6.4.3圖表-按渠道劃分的全球市場-基準年6.4.4圖表-按渠道劃分的全球市場-年終6.4.5圖表-按渠道劃分的全球市場-按年劃分的份額6.4.6圖表-按渠道劃分的全球市場-細分市場增長
7 Global COVID-19 Diagnostic Markets - By Technology
7.1 PCR
7.1.1 Table PCR - by Country
7.1.2 Chart - PCR Growth
7.2 PCR Multiplex
7.2.1 Table PCR Multiplex - by Country
7.2.2 Chart - PCR Multiplex Growth
7.3 Sequencing
7.3.1 Table Sequencing - by Country
7.3.2 Chart - Sequencing Growth
7.4 Antibody
7.4.1 Table Antibody - by Country
7.4.2 Chart - Antibody Growth
7.5 Antigen
7.5.1 Table Antigen - by Country
7.5.2 Chart - Antigen Growth
7個全球新冠肺炎診斷市場-按技術分類7.1 PCR7.1.1表PCR-按國家/地區7.1.2圖表-PCR增長7.2多聚酶鏈反應(PCR Multiplex)7.2.1表PCR多路複用-按國家/地區7.2.2 Chart-PCR複合生長7.3測序7.3.1表格排序-按國家/地區排序7.3.2圖表-排序增長7.4抗體7.4.1表抗體-按國家/地區7.4.2圖表-抗體增長7.5抗原7.5.1表格抗原-按國家/地區7.5.2圖表-抗原生長
8 Global COVID-19 Diagnostic Markets - By Product
8.1 Instruments
8.1.1 Table Instruments - by Country
8.1.2 Chart - Instruments Growth
8.2 Reagents & Kits
8.2.1 Table Reagents & Kits - by Country
8.2.2 Chart - Reagents & Kits Growth
8.3 Extraction
8.3.1 Table Extraction - by Country
8.3.2 Chart - Extraction Growth
8.4 Collection
8.4.1 Table Collection - by Country
8.4.2 Chart - Collection Growth
8個全球新冠肺炎診斷市場(按產品分類)8.1儀器8.1.1台式儀器-按國家/地區8.1.2圖表-儀器增長8.2試劑和試劑盒8.2.1表用試劑和試劑盒-按國家/地區8.2.2圖表-試劑和試劑盒增長8.3提取8.3.1表格提取-按國家/地區8.3.2圖表提取增長8.4集合8.4.1表格收款-按國家/地區8.4.2圖表-收藏增長
9 Global COVID-19 Diagnostic Markets - By Channel
9.1 Public
9.1.1 Table Public - by Country
9.1.2 Chart - Public Growth
9.2 Hospital
9.2.1 Table Hospital - by Country
9.2.2 Chart - Hospital Growth
9.3 Clinic
9.3.1 Table Clinic - by Country
9.3.2 Chart - Clinic Growth
9.4 Workplace
9.4.1 Table Workplace - by Country
9.4.2 Chart - Workplace Growth
9.5 DTC/OTC
9.5.1 Table DTC/OTC - by Country
9.5.2 Chart - DTC/OTC Growth
9.6 Wastewater
9.6.1 Table Wastewater - by Country
9.6.2 Chart - Wastewater Growth
9個全球新冠肺炎診斷市場(按渠道)9.1公眾9.1.1表公開-按國家/地區9.1.2圖表-公眾增長9.2醫院9.2.1表格醫院-按國家/地區9.2.2圖表-醫院增長9.3診所9.3.1餐桌診所-按國家/地區9.3.2圖表-診所增長9.4工作場所9.4.1工作台-按國家/地區9.4.2圖表-工作場所增長9.5 DTC/OTC9.5.1表DTC/OTC-按國家/地區9.5.2圖表-DTC/OTC增長9.6廢水9.6.1餐桌廢水-按國家/地區9.6.2圖表-廢水增長
10 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/9qb3j2
10附錄有關本報告的更多信息，請訪問https://www.researchandmarkets.com/r/9qb3j2。
Media Contact:
媒體聯繫人：
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
研究和市場勞拉·伍德(Laura Wood)，高級經理[受電子郵件保護]對於E.S.T辦公時間，請撥打電話：+1-917-300-0470美國/加拿大免費電話：+1-800-526-8630對於格林尼治標準時間辦公時間，請致電+353-1-416-8900美國傳真：646-607-1907傳真(美國境外)：+353-1-481-1716
SOURCE Research and Markets
來源研究和市場
Related Links
相關鏈接
http://www.researchandmarkets.com
Http://www.researchandmarkets.com
譯文內容由第三人軟體翻譯。